Empire Industries share price & results
- Jun 2026
- Sept 2026
Mumbai-based diversified industrial group running seven divisions: pharma glass-bottle manufacturing (Vitrum Glass), machine tools, industrial equipment, vending (GRABBIT), foods retail and industrial real estate.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 184 | +10.2% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 11.0 | +2.0 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 14.0 | +40.0% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
| Return on equity | +9.4 pts | Trailing twelve months | TTM · period unavailable | Not in the analysed materials. No older figure is substituted. | |
| Free cash flow margin | Fiscal year | FY · period unavailable | Not in the analysed materials. No older figure is substituted. | ||
| Revenue growth (YoY) | −11.6 pts | Trailing twelve months | TTM · period unavailable | Not in the analysed materials. No older figure is substituted. |
Price
Performance −12.1% 1Y
1Y: ₹1,070.85 on 24 Oct 2025 → ₹941.6. High ₹1,221.8 (26 Aug 2026), low ₹825.1 (23 Mar 2026).
- Previous close
- ₹933.8
- Market cap
- ₹566 Cr
- 52-week range
- ₹825.1 – ₹1,221.8
- One year
- −11.59%
Overview
- Symbol
- NSE:EMPIND
- Sector
- Diversified
- Exchange
- NSE
- Currency
- INR
What Empire Industries Ltd. does
Based on the company's own presentations, annual report and earnings calls.
Empire Industries is a Mumbai-headquartered diversified industrial group organised into distinct operating divisions. Its Vitrum Glass division manufactures and markets pharmaceutical-grade glass bottles from a fully automated plant in Vikhroli, Mumbai, producing over 1.9 million bottles a day (5ml to 650ml) for clients including Merck India, GlaxoSmithKline, Abbott India, Cipla, Ajanta Pharma, Zydus and Himalaya. The remaining divisions are Empire Machine Tools, Empire Industrial Equipment, Empire Vending (branded GRABBIT), Empire Foods (a food & grocery retail business recognised as Independent Food & Grocery Retailer of the Year 2016 and Category Champion at METRO Cash & Carry 2017), and real-estate/industrial-park operations under The Empire Business Centre and Empire Industrial Centrum, an award-winning industrial park development.
Segments
- Vitrum Glass
- Empire Machine Tools
- Empire Industrial Equipment
- Empire Vending (GRABBIT)
- Empire Foods
- The Empire Business Centre
- Empire Industrial Centrum
- Manufacturing plants
- 1 (Vitrum Glass plant, Vikhroli, Mumbai)
- Installed capacity (Vitrum Glass)
- 1.9 million+ bottles/day (5ml–650ml)
- Business divisions
- 7 (Vitrum Glass, Empire Machine Tools, Empire Industrial Equipment, Empire Vending/GRABBIT, Empire Foods, Empire Business Centre, Empire Industrial Centrum)
- Major pharma clients served (Vitrum Glass)
- Merck India, GlaxoSmithKline, Abbott India, Cipla, Ajanta Pharma, Zydus, Himalaya and others
Fundamentals
Ratios, each with its period
Current values with the period they cover; the trend reads across the 4 fiscal years held (Mar 2002 to Mar 2005).
Financials
What the filings say
Net profit, year on year: +40% (quarter to jun 2026 against jun 2025).
| Line item | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 163 | 176 | 186 | 167 | 180 | 189 | 195 | 184 |
| Expenses | 144 | 158 | 170 | 151 | 159 | 171 | 162 | 164 |
| Operating profit | 19 | 18 | 16 | 15 | 21 | 17 | 33 | 20 |
| Operating margin | 12.0% | 10.0% | 9.0% | 9.0% | 12.0% | 9.0% | 17.0% | 11.0% |
| Other income | 4 | 5 | 3 | 3 | 5 | 5 | 5 | 6 |
| Interest | 7 | 7 | 8 | 5 | 8 | 6 | 10 | 5 |
| Depreciation | 4 | 4 | 5 | 4 | 4 | 4 | 4 | 4 |
| Profit before tax | 11 | 12 | 6 | 10 | 14 | 12 | 24 | 17 |
| Tax rate | 13.0% | 9.0% | 32.0% | 7.0% | 10.0% | 12.0% | 21.0% | 17.0% |
| Net profit | 10 | 11 | 4 | 10 | 12 | 11 | 19 | 14 |
| EPS (₹ per share) | 16.35 | 17.53 | 7.40 | 16.03 | 20.65 | 17.63 | 31.58 | 23.62 |
| Line item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 682 | 607 | 677 | 731 |
| Expenses | 604 | 542 | 607 | 643 |
| Operating profit | 79 | 65 | 69 | 86 |
| Other income | 14 | 25 | 15 | 18 |
| Interest | 33 | 27 | 27 | 29 |
| Depreciation | 16 | 16 | 17 | 16 |
| Profit before tax | 42 | 45 | 40 | 60 |
| Net profit | 36 | 37 | 35 | 52 |
| Line item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 250 | 277 | 294 | 308 | 319 | 345 |
| Borrowings | 232 | 183 | 168 | 150 | 182 | 172 |
| Other liabilities | 219 | 274 | 256 | 286 | 301 | 292 |
| Total liabilities | 707 | 740 | 724 | 751 | 809 | 815 |
| Fixed assets | 352 | 317 | 315 | 304 | 299 | 301 |
| Capital work in progress | 9 | 9 | 0 | 0 | 3 | 2 |
| Investments | 0 | 1 | 29 | 11 | 59 | 60 |
| Other assets | 346 | 412 | 380 | 435 | 448 | 453 |
| Total assets | 707 | 740 | 724 | 751 | 809 | 815 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operations | 103 | 53 | 79 | 75 | 92 | 59 |
| Cash from investing | -4 | -2 | 29 | -15 | 17 | -51 |
| Cash from financing | -82 | -45 | -89 | -52 | -59 | -20 |
| Net cash flow | 17 | 6 | 19 | 7 | 50 | -13 |
| Free cash flow | 96 | 44 | 103 | 64 | 86 | 46 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor days | 64 | 83 | 104 | 97 | 76 | 68 |
| Inventory days | 254 | 252 | 161 | 180 | 137 | 186 |
| Days payable | 34 | 41 | 58 | 51 | 55 | 55 |
| Cash conversion cycle | 284 | 294 | 207 | 226 | 158 | 199 |
| Working capital days | 40 | 56 | 56 | 23 | 19 | 36 |
| Return on capital employed | 9.0% | 11.0% | 16.0% | 15.0% | 14.0% | 18.0% |
| Dividend payout | 114.0% | 63.0% | 42.0% | 41.0% | 44.0% | 29.0% |
Where revenue comes from
The businesses behind the company’s reported revenue.
Manufacturing contributes 40.9% of reported segment revenue.
Quarter ended 30 Jun 2026 · Standalone
- Manufacturing 40.9%
₹75.14 crore
- Trading and Indenting 40.3%
₹73.91 crore
- Others 14.0%
₹25.78 crore
- Property Development 4.8%
₹8.77 crore
| Business segment | Revenue · ₹ crore | Share |
|---|---|---|
| Manufacturing | 75.14 | 40.9% |
| Trading and Indenting | 73.91 | 40.3% |
| Others | 25.78 | 14.0% |
| Property Development | 8.77 | 4.8% |
Share = segment revenue ÷ total segment revenue, before intersegment adjustments.
How these numbers add up
- Total segment revenue
- ₹183.60 crore
- Intersegment adjustment
- ₹0.00 crore
- Net segment revenue
- ₹183.60 crore
Intersegment transactions are between the company’s own businesses. Net segment revenue can differ from income-statement revenue because reporting definitions differ.
Source: FinEdge · Last checked 19 Sept 2026. Reported segment names are kept as supplied.
What the price assumes
AttractiveTo justify its price of ₹942, this stock must grow earnings at 3% every year for 7 years. Our analysis caps realistic growth at ~13%. At that growth it is worth ₹1615 — upside of 72%.
- Growth the price implies
- 3.2% a year
- for 7 years, fading to 4%
- It has actually compounded at
- 13.1% a year
- net profit, FY23–FY26 · EPS 13.2%
- The gap
- -0.1 pp
- 72% downside if it only repeats history
Ownership
Who owns it
Promoters hold 72.55% as of Sept 2026; institutions cut 0.10 pts since Jun 2026.
- Promoters 72.55%
- Domestic institutions 5.85%
- Public 21.59%
Who is on the register
Named in the Sep 2026 filing
Every holder of Empire Industries Ltd. above SEBI's 1% disclosure line, and what changed since Jun 2026.
| Holder | Stake | Change |
|---|---|---|
| 27.05% | unchanged | |
| 18.59% | unchanged | |
| 18.53% | unchanged | |
| Insurer | 5.85% | −0.10 pp |
| 3.26% | unchanged | |
| 2.12% | unchanged | |
| 2.09% | unchanged | |
| 0.21% | unchanged | |
| 0.20% | unchanged | |
| 0.17% | unchanged | |
| 0.17% | unchanged | |
| 0.17% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Your own record
Start an Inve Case for Empire Industries Ltd.
Free account: one company. Everything above stays public.
Write why you follow Empire Industries Ltd. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading
Other Diversified companies
Learn to analyse Empire Industries Ltd.
Guides on how to read this kind of business and the numbers that matter.